251 related articles for article (PubMed ID: 28842833)
1. Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.
Brodowicz J; Przegaliński E; Müller CP; Filip M
Neurotox Res; 2018 Feb; 33(2):474-484. PubMed ID: 28842833
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
3. The role of ceramide in major depressive disorder.
Kornhuber J; Reichel M; Tripal P; Groemer TW; Henkel AW; Mühle C; Gulbins E
Eur Arch Psychiatry Clin Neurosci; 2009 Nov; 259 Suppl 2():S199-204. PubMed ID: 19876679
[TBL] [Abstract][Full Text] [Related]
4. Doxepin Mitigates Noise-induced Neuronal Damage in Primary Auditory Cortex of Mice via Suppression of Acid Sphingomyelinase/Ceramide Pathway.
Su YT; Meng XX; Zhang X; Guo YB; Zhang HJ; Cheng YP; Xie XP; Chang YM; Bao JX
Anat Rec (Hoboken); 2017 Dec; 300(12):2220-2232. PubMed ID: 28806500
[TBL] [Abstract][Full Text] [Related]
5. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs.
Gulbins E; Palmada M; Reichel M; Lüth A; Böhmer C; Amato D; Müller CP; Tischbirek CH; Groemer TW; Tabatabai G; Becker KA; Tripal P; Staedtler S; Ackermann TF; van Brederode J; Alzheimer C; Weller M; Lang UE; Kleuser B; Grassmé H; Kornhuber J
Nat Med; 2013 Jul; 19(7):934-8. PubMed ID: 23770692
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease.
Choi BJ; Park MH; Jin HK; Bae JS
Exp Mol Med; 2024 Feb; 56(2):301-310. PubMed ID: 38337058
[TBL] [Abstract][Full Text] [Related]
7. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles.
Mohamud Yusuf A; Hagemann N; Zhang X; Zafar M; Hussner T; Bromkamp C; Martiny C; Tertel T; Börger V; Schumacher F; Solari FA; Hasenberg M; Kleinschnitz C; Doeppner TR; Kleuser B; Sickmann A; Gunzer M; Giebel B; Kolesnick R; Gulbins E; Hermann DM
Basic Res Cardiol; 2022 Dec; 117(1):43. PubMed ID: 36038749
[TBL] [Abstract][Full Text] [Related]
8. Acid sphingomyelinase/ceramide regulates carotid intima-media thickness in simulated weightless rats.
Cheng YP; Zhang HJ; Su YT; Meng XX; Xie XP; Chang YM; Bao JX
Pflugers Arch; 2017 Jun; 469(5-6):751-765. PubMed ID: 28357491
[TBL] [Abstract][Full Text] [Related]
9. Regulation of sphingomyelin metabolism.
Bienias K; Fiedorowicz A; Sadowska A; Prokopiuk S; Car H
Pharmacol Rep; 2016 Jun; 68(3):570-81. PubMed ID: 26940196
[TBL] [Abstract][Full Text] [Related]
10. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease.
Lee JK; Jin HK; Park MH; Kim BR; Lee PH; Nakauchi H; Carter JE; He X; Schuchman EH; Bae JS
J Exp Med; 2014 Jul; 211(8):1551-70. PubMed ID: 25049335
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
12. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.
de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE
J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelins and ceramides: possible biomarkers for dementia?
Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.
Qi YY; Heng X; Yao ZY; Qu SY; Ge PY; Zhao X; Ni SJ; Guo R; Yang NY; Zhang QC; Zhu HX
Drug Des Devel Ther; 2022; 16():931-950. PubMed ID: 35391788
[TBL] [Abstract][Full Text] [Related]
15. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
Crivelli SM; Luo Q; Kruining DV; Giovagnoni C; Mané-Damas M; den Hoedt S; Berkes D; De Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Wijnands EPM; Bieberich E; Losen M; Martinez-Martinez P
Biomed Pharmacother; 2022 Aug; 152():113240. PubMed ID: 35689862
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
[TBL] [Abstract][Full Text] [Related]
17. Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target.
Zhuo C; Zhao F; Tian H; Chen J; Li Q; Yang L; Ping J; Li R; Wang L; Xu Y; Cai Z; Song X
Transl Psychiatry; 2022 Jun; 12(1):260. PubMed ID: 35739089
[TBL] [Abstract][Full Text] [Related]
18. Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation.
Jiang J; Shi Y; Cao J; Lu Y; Sun G; Yang J
Lipids Health Dis; 2021 Feb; 20(1):19. PubMed ID: 33612104
[TBL] [Abstract][Full Text] [Related]
19. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers.
Sot J; Bagatolli LA; Goñi FM; Alonso A
Biophys J; 2006 Feb; 90(3):903-14. PubMed ID: 16284266
[TBL] [Abstract][Full Text] [Related]
20. mRNA Expression of
Rhein C; Zoicas I; Marx LM; Zeitler S; Hepp T; von Zimmermann C; Mühle C; Richter-Schmidinger T; Lenz B; Erim Y; Reichel M; Gulbins E; Kornhuber J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
